Featured

Feature: Nigerian Gets CRI Recognition For Cancer Cure

Published

6 years ago

August 28, 2019

Nigeria has lost several persons, including well-known and admirable personalities to cancer. This list includes former Director-General, DG of the National Institute of the National Agency for Food and Drug Administration and Control, NAFDAC, Prof. Dora Akunyili; former First Lady, Hajiya Mariam Babangida; wife of former Managing Director of the Niger Delta Development Commission, NDDC, Aliere Alaibe, and legal icon and human rights activist, Gani Fawehinmi (SAN). Some say the death of these highly placed individuals acted as some form of wake up call to Nigeria that indeed cancer is silently killing many of its citizens.

A first and obvious breakthrough was recorded when on August 16, the Cancer Research Institute, CRI, a non-profit organisation founded in the United States of America in1953 and dedicated exclusively to advancing immunotherapy to treat, control, and cure all cancers wrote to a Nigerian researcher, Ben Amodu, recognising the fact that his research has the potentials to change the narrative in cancer cure.

“We believe your research has the potential to change many lives for the wellbeing of millions suffering especially in Africa where it (cancer) is prevalent. We also believe your products can qualify for our $175,000 Immunotherapy advancement Grant for immunotherapy which is geared at propelling such meticulous research into full-blown treatments available for disbursements” the NCI stated.

The NCI is requesting letters of intent for its Clinic and Laboratory Integration Programme, CLIP, offering grants to qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The grant will support basic, pre-clinical, and translational research that will provide information that can be directly applied to optimizing cancer immunotherapy in the clinic.

Cancer has become a huge menace in today’s society. The name cancer is now associated with death. The treatment is usually expensive, in addition to other side effects. For instance, ‘Chemotherapy’ is not only painful but causes loss of hair. It is a system whereby drugs are injected into the patients’ veins. October has been tagged as the ‘breast cancer awareness month.’ This is in a bid to create awareness worldwide.

According to the National Cancer Institute, Cancer is the name given to a collection of related diseases. In all types of cancer, some of the body’s cells begin to divide without stopping and spread into surrounding tissues. Cancer can start almost anywhere in the human body, which is made up of trillions of cells. Normally, human cells grow and divide to form new cells as the body needs them. When cells grow old or become damaged, they die, and new cells take their place.

When cancer develops, however, this orderly process breaks down. As cells become more and more abnormal, old or damaged cells survive when they should die, and new cells form when they are not needed. These extra cells can divide without stopping and may form growths called tumors. Many cancers form solid tumors, which are masses of tissue.

Cancers of the blood, such as leukemias, generally do not form solid tumors. Cancerous tumors are malignant, which means they can spread into, or invade nearby tissues. In addition, as these tumors grow, some cancer cells can break off and travel to distant places in the body through the blood or the lymph system and form new tumors far from the original tumor. Unlike malignant tumors, benign tumors do not spread into, or invade nearby tissues. Benign tumors can sometimes be quite large. When removed, they usually don’t grow back, but malignant tumors do.

According to research, each cancer is thought to first start from one abnormal cell. What happens is that certain vital genes that control how cells divide and multiply are damaged or altered. This makes the cell abnormal. If the abnormal cell survives it may multiply out of control into a cancerous (malignant) tumor.

Experts say we all have a risk of developing cancer. Many cancers seem to develop for no apparent reason; certain risk factors are known to increase the chance that one or more of your cells will become abnormal and lead to cancer. Risk factors include the following: lifestyle e.g. smoking, lack of physical activity; diets, certain types of infections; such as human papillomaviruses, HPV, Helicobacter pylori, and hepatitis B, HBV, and hepatitis C viruses, HCV, and environmental exposures to different types of chemicals and radiation.

The NSIA-LUTH Cancer Centre which was commissioned recently by President Muhammadu Buhari opened for patients on May 1. The ultra-modern equipment has undergone the necessary calibrations and fine-tuned to comply with international standards before going to operate. “The rigorous steps are a must before international and local regulatory bodies can certify any high-end irradiating equipment for use on patients,” the CMD, Prof. Chris Bode said.

He also disclosed that the center, financed by the Nigeria Sovereign Investment Authority, NSIA, is designed in compliance with international best practices while requisite personnel including radiotherapists, oncologists, physicists, and nurses are currently undergoing conversion training in readiness for the smooth take-off of services at the center. He added that the multi-billion cancer center was established as a joint-venture partnership between the NSIA and LUTH to address the lack of adequate and comprehensive cancer treatment and management in the country.

Cancer can be treated by surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy (including immunotherapy such as monoclonal antibody therapy) and synthetic lethality. The choice of therapy depends upon the location and grade of the tumor and the stage of the disease, as well as the general state of the patient (performance status). Cancer genome sequencing helps in determining which cancer the patient exactly has for determining the best therapy for cancer. A number of experimental cancer treatments are also under development. Under current estimates, two in five people will have cancer at some point in their lifetime.

Complete removal of cancer without damage to the rest of the body (that is, achieving cure with near-zero adverse effects) is the ideal goal of treatment and is often the goal in practice. Sometimes this can be accomplished by surgery, but the propensity of cancers to invade adjacent tissue or to spread to distant sites by microscopic metastasis often limits its effectiveness, and chemotherapy and radiotherapy can have a negative effect on normal cells.

Therefore, cure with non-negligible adverse effects may be accepted as a practical goal in some cases; and besides curative intent, practical goals of therapy can also include (1) suppressing cancer to a subclinical state and maintaining that state for years of good quality of life (that is, treating cancer as a chronic disease), and (2) palliative care without curative intent (for advanced-stage metastatic cancers).

Because “cancer” refers to a class of diseases, it is unlikely that there will ever be a single” cure for cancer” any more than there will be a single treatment for all infectious diseases. Angiogenesis inhibitors were once thought to have potential as a “silver bullet” treatment applicable to many types of cancer, but this has not been the case in practice.

Speaking to AljazirahNigeria, Ben Amodu said: “American scientists visited me here about five years ago in my lab, took five samples of my drugs that can treat colon cancer. I never followed them to the U.S, specifically the state of Texas. They started the analysis, first on colon cancer, and then they discovered it can treat colon cancer, and saw that it was doing very well up to 80-89 % in resolving colon cancer.

While they were doing this research, they discovered the drug could resolve lung cancer. They hurriedly set up another experiment on the product and they got 80-89% for both cancers’ I was not there. These things were reported based on scientific procedure, the discovery was presented to a gathering of 18,000 America scientists where the discovery was crowned as a lead discovery and as we speak today we are making use of that product to cure Asthma which has no cure anywhere in the world because of its effect on the lungs. Cancer of the lungs is the highest disease of the lungs, so asthma is child’s play and truly we use it on asthma patients and we’ve cured several.” This was prior to the NCI confirmation.

And for Nigerians and the world at large, the end might just be in sight for a lasting cure to Cancer, one of the leading killer diseases.

Share on Facebook

Featured

NELFUND: The Renewed Hope Engine Propelling Nigeria’s Youth into Tomorrow

Published

3 days ago

November 28, 2025

The Gleamer

By Dayo Israel, National Youth Leader, APC

As the National Youth Leader of the All Progressives Congress, I have spent most of my tenure fighting for a Nigeria where every young person, regardless of their ward or local government, family income, or circumstance, can chase dreams without the chains of financial despair.

Today, that fight feels like victory, thanks to the Nigerian Education Loan Fund (NELFUND). Launched as a cornerstone of President Bola Ahmed Tinubu’s Renewed Hope Agenda, this initiative isn’t just a policy tweak; it’s a revolution. And under the steady, visionary hand of Managing Director Akintunde Sawyerr, NELFUND has transformed from a bold promise into a roaring engine of opportunity, disbursing over ₦116 billion to more than 396,000 students and shattering barriers for over a million applicants.

Let’s be clear: NELFUND was always destined to be a game-changer. Signed into law by President Tinubu on April 3, 2024, it repealed the outdated 2023 Student Loan Act, replacing it with a modern, inclusive framework that covers tuition, upkeep allowances, and even vocational training—ensuring no Nigerian youth is left on the sidelines of progress.

But what elevates it from groundbreaking to generational? Leadership. Enter Akintunde Sawyerr, the diplomat-turned-executioner whose career reads like a blueprint for results-driven governance. From co-founding the Agricultural Fresh Produce Growers and Exporters Association of Nigeria (AFGEAN) in 2012—backed by icons like former President Olusegun Obasanjo and Dr. Akinwumi Adesina—to steering global logistics at DHL across 21 countries, Sawyerr brings a rare alchemy: strategic foresight fused with unyielding accountability.

As NELFUND’s pioneer MD, he’s turned a fledgling fund into a finely tuned machine, processing over 1 million applications since May 2024 and disbursing ₦116 billion—₦61.33 billion in institutional fees and ₦46.35 billion in upkeep—to students in 231 tertiary institutions nationwide. That’s not bureaucracy; that’s brilliance.

Sawyerr’s touch is everywhere in NELFUND’s ascent. Since the portal’s launch, he’s overseen a digital ecosystem that’s as transparent as it is efficient—seamless verification, BVN-linked tracking, and real-time dashboards that have quashed misinformation and built trust. In just 18 months, the fund has empowered 396,252 students with interest-free loans, many first-generation learners who might otherwise have dropped out.

Sensitization drives in places like Ekiti and Ogun have spiked applications — 12,000 in a single day in one instance, while expansions to vocational centers in Enugu pilot the next wave of skills-based funding. And amid challenges like data mismatches and fee hikes, Sawyerr’s team has iterated relentlessly: aligning disbursements with academic calendars, resuming backlogged upkeep payments for over 3,600 students, and even probing institutional compliance to safeguard every kobo. This isn’t management; it’s mastery—a man who doesn’t just lead but launches futures.

Yet, none of this happens in a vacuum. President Tinubu’s alliance with trailblazers like Sawyerr is the secret sauce securing Nigeria’s tomorrow. The President’s Renewed Hope Agenda isn’t rhetoric; it’s resources—₦100 billion seed capital channeled into a system that prioritizes equity over elitism. Together, they’ve forged a partnership where vision meets velocity: Tinubu’s bold repeal of barriers meets Sawyerr’s boots-on-the-ground execution, turning abstract policy into tangible triumphs. It’s a synergy that’s non-discriminatory by design—Christians, Muslims, every tribe and tongue united in access—fostering national cohesion through classrooms, not courtrooms.

As Sawyerr himself notes, this is “visionary leadership” in action, where the President’s political will ignites reforms that ripple across generations.

Why does this matter to us, Nigeria’s youth? Because NELFUND isn’t handing out handouts—it’s handing out horizons. In a country where 53% of us grapple with unemployment, these loans aren’t just funds; they’re fuel for innovation, entrepreneurship, and endurance.

Picture it: A first-generation polytechnic student in Maiduguri, once sidelined by fees, now graduates debt-free (repayments start two years post-NYSC, employer-deducted for ease) and launches a tech startup. Or a vocational trainee in Enugu, equipped with skills funding, revolutionizing local agriculture. This is quality education that endures—not fleeting certificates, but lifelong launchpads. Sawyerr’s focus on human-centered design ensures loans cover not just books, but bread—upkeep stipends of ₦20,000 monthly keeping hunger at bay so minds can soar. Under his watch, NELFUND has debunked doubts, refuted fraud claims, and delivered results that scream sustainability: Over ₦99.5 billion to 510,000 students by September, with 228 institutions on board.

As youth leaders, we see NELFUND for what it is: A covenant with our future. President Tinubu and MD Sawyerr aren’t just allies; they’re architects of an educated, empowered Nigeria—one where poverty’s grip loosens with every approved application, and innovation blooms from every funded desk. This isn’t charity; it’s an investment in the 70 million of us who will lead tomorrow.

We’ve crossed one million applications not because of luck, but leadership—a duo that’s turning “access denied” into “future unlocked.”

To President Tinubu: Thank you for daring to dream big and backing it with action.

To Akintunde Sawyerr: You’re the executor we needed, proving that one steady hand can steady a nation.

And to every Nigerian youth: Apply. Graduate. Conquer.

Because with NELFUND, your generation isn’t just surviving—it’s thriving, enduring, and eternal.

The Renewed Hope isn’t a slogan; it’s our story, now written in scholarships and success. Let’s keep turning the page.

Dayo Israel is the National Youth Leader of the All Progressives Congress (APC).

Share on Facebook